International Clinical Trial: A randomised, double-blind, placebo-controlled study of Phase ? was conducted to demonstrate the safety and preliminary efficacy of escalating of ALT001 in patients

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115074) titled 'A randomised, double-blind, placebo-controlled study of Phase ? was conducted to demonstrate the safety and preliminary efficacy of escalating of ALT001 in patients' on Dec. 22, 2025.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Beijing Tiantan Hospital, Capital Medical University

Condition: Amyotrophic lateral sclerosis

Intervention: Experimental group:Calculate the dosage according to body weight. Dissolve ALT001 in 100ml of normal saline injection and administer it by intravenous once daily.Single-dose administration. Multiple-dose administration: A treatment cycle consists ...